Achmea Investment Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-42,612
Closed -$3.15M 374
2024
Q4
$3.15M Sell
42,612
-7,778
-15% -$576K 0.05% 255
2024
Q3
$3.33M Hold
50,390
0.05% 265
2024
Q2
$4.66M Hold
50,390
0.08% 222
2024
Q1
$4.82M Hold
50,390
0.09% 220
2023
Q4
$3.84M Sell
50,390
-13,819
-22% -$1.05M 0.08% 248
2023
Q3
$4.45M Sell
64,209
-2,144
-3% -$149K 0.1% 218
2023
Q2
$6.26M Buy
66,353
+20,682
+45% +$1.95M 0.13% 175
2023
Q1
$3.78M Buy
45,671
+13,765
+43% +$1.14M 0.11% 205
2022
Q4
$2.23M Hold
31,906
0.07% 267
2022
Q3
$2.64M Sell
31,906
-10,373
-25% -$857K 0.09% 230
2022
Q2
$4.02M Sell
42,279
-11,009
-21% -$1.05M 0.13% 178
2022
Q1
$6.27M Buy
53,288
+962
+2% +$113K 0.16% 154
2021
Q4
$6.78M Sell
52,326
-1,632
-3% -$211K 0.32% 69
2021
Q3
$6.11M Buy
53,958
+1,361
+3% +$154K 0.19% 148
2021
Q2
$5.45M Hold
52,597
0.19% 149
2021
Q1
$4.4M Sell
52,597
-1,693
-3% -$142K 0.15% 180
2020
Q4
$4.95M Buy
54,290
+42
+0.1% +$3.83K 0.18% 155
2020
Q3
$4.33M Buy
+54,248
New +$4.33M 0.18% 150
2020
Q1
Sell
-79,389
Closed -$6.17M 355
2019
Q4
$6.17M Sell
79,389
-12,390
-13% -$963K 0.24% 104
2019
Q3
$6.73M Buy
91,779
+30,279
+49% +$2.22M 0.27% 97
2019
Q2
$3.79M Buy
+61,500
New +$3.79M 0.14% 172
2019
Q1
Sell
-68,286
Closed -$3.49M 443
2018
Q4
$3.49M Buy
68,286
+5,118
+8% +$261K 0.16% 142
2018
Q3
$3.67M Buy
63,168
+27,867
+79% +$1.62M 0.14% 185
2018
Q2
$1.71M Hold
35,301
0.06% 296
2018
Q1
$1.64M Hold
35,301
0.06% 321
2017
Q4
$1.33M Buy
35,301
+7,554
+27% +$284K 0.04% 353
2017
Q3
$1.01M Hold
27,747
0.06% 326
2017
Q2
$1.09M Hold
27,747
0.07% 319
2017
Q1
$870K Buy
+27,747
New +$870K 0.04% 383